All Stories

  1. Actin remodeling confers BRAF inhibitor resistance
  2. ALK amplification in inflammatory breast cancer
  3. Impact of cigarette smoking on EGFR TKI response
  4. ALK and ROS1 fusion in never smoker lung adenocarcinoma
  5. Abstract 1212: Anaplastic lymphoma kinase (ALK) gene copy number gain in inflammatory breast cancer (IBC): frequency, clinicopathologic features and prognostic implication .
  6. FOXP3 Expression predicts poor prognosis of breast cancer patients